Preparation of herbal tea as infusion or by maceration at room temperature using mistletoe tea as an example

Scientia Pharmaceutica

Volumn 79, Issue 1, 2011, Pages 145-155

  Jäger, Sebastian ^a,b   Beffert, Markus ^a   Hoppe, Katharina ^a   Nadberezny, Dominik ^a   Frank, Bruno ^c   Scheffler, Armin ^a  

^a Carl Gustav Carus Institut   (Germany)

^b Betulin Institute   (Germany)

^c Kneipp Werke   (Germany)

Author keywords

ELISA; Extraction Chromatographic profile; GC; Herbal tea; HPLC; Infusion; Maceration; Mistletoe; Viscum album L.

Indexed keywords

BETA AMYRIN; BETULIC ACID; LUPEOL ACETATE; NATURAL PRODUCT; OLEANOLIC ACID; RUTOSIDE; SYRINGIN; UNCLASSIFIED DRUG; VISCOTOXIN; VISCUM ALBUM EXTRACT; VISCUM ALBUM LECTIN;

ARTICLE; DRUG ISOLATION; EXTRACTION; ROOM TEMPERATURE; SOLID PHASE EXTRACTION; TEA;

EID: 79952933292     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1006-06     Document Type: Article

References (31)

1. Schilcher H, Frank B. Kleines Heilkräuter-Lexikon. 5 ed. Hädecke Verlag; 2008.
2. Madaus G. Lehrbuch der biologischen Heilmittel, Abteilung I: Heilpflanzen, Band III. Georg Thieme Verlag Leipzig; 1938. p. 2841.
3. Wichtl M. Visci herba DAB. In: Wichtl M, editor. Teedrogen und Phytopharmaka: Ein Handbuch für Praxis auf wissenschaftlicher Grundlage. 5. Auflage, Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 2009. p. 711-714.
4. Büssing A. Introduction: History of mistletoe uses. In: Büssing A, editor. 16, Mistletoe the genus viscum. Amsterdam: Harwood Academic Publishers; 2000. p. 1-6.
5. Büssing A. Overview on Viscum album L. products. In: Büssing A, editor. 16, Mistletoe the genus viscum. Amsterdam: Harwood Academic Publishers; 2000. p. 209-221.
6. Büssing A. Biological and pharmacological properties of Viscum album L. In: Büssing A, editor. 16, Mistletoe the genus viscum. Amsterdam: Harwood Academic Publishers; 2000. p. 123-182.
7. Wagner H, Feil B, Seligmann O, Petricic J, Kalogjera Z. Phenylpropanes and lignans of Viscum album cardioactive drugs V. Planta Med. 1986; 52: 102-104. doi:10.1055/s-2007-969090
8. Lorch E, Tröger W. Pharmaceutical quality control of mistletoe preparations. In: Büssing A, editor. 16, Mistletoe the genus viscum. Amsterdam: Harwood Academic Publishers; 2000. p. 223-235.
9. Deliorman D, Calis I, Ergun F, Dogan BS, Buharalioglu CK, Kanzik I. Studies on the vascular effects of the fractions and phenolic compounds isolated from Viscum album ssp. album. J Ethnopharmacol. 2000; 72: 323-329. doi:10.1016/S0378-8741(00)00251-8
10. Bowman IA. The everlasting mistletoe and the cardiovascular system. Tex Heart Inst J. 1990; 17: 310-314. PMid:15227523
11. Wagner H, Feil B, Bladt S. Analyse und Standardisierung von Arzneidrogen und Phytopräparatn durch Hochleistungsflüssigchromatographie (HPLC) und andere chromatographische Verfahren (III). Dtsch Apth Ztg. 1984; 124: 1429-1432.
12. Laszczyk MN. Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med. 2009; 75: 1549-1560. doi:10.1055/s-0029-1186102
13. Jäger S, Winkler K, Pfüller U, Scheffler A. Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L. Planta Med. 2007; 73: 157-162. doi:10.1055/s-2007-967106
14. Urech K, Schaller G, Jäggy C. Wachstum und Giftsubstanzbildung der generativen Organe der Mistel (Viscum album L.). Mistilteinn. 2005; 6: 18-31.
15. Jäger S, Trojan H, Kopp T, Laszczyk MN, Scheffler A. Pentacyclic triterpene distribution in various plants-rich sources for a new group of multi-potent plant extracts. Molecules. 2009; 14: 2016-2031. doi:10.3390/molecules14062016
16. Jäger S. Qualitative und quantitative Untersuchungen von Triterpenoiden in Viscum album L. und deren wässrigen Extrakten sowie Versuche zur Verbesserung der Extraktionsverfahren [Inaugural-Dissertation zur Erlangung des Grades eines Doktors der Naturwissenschaften]. Witten: Universität Witten/Herdecke; 2005.215.
17. Krüger D, Frank B. Qualitätssicherung von Mistel und Mistelzubereitungen. Pharm Ztg. 1986; 41: 2540-2542.
18. Fukunaga T, Kajikawa I, Nishiya K, Watanabe Y, Takeya K, Itokawa H. Studies on the constituents of the european Mistletoe, Viscum album L. Chem Pharm Bull. 1987; 35: 3292-3297.
19. Pfüller U. Chemical constituents of european mistletoe (Viscum album L.). Isolation and characterisation of the main relevant ingredients: lectins, viscotoxins, olig-/polysaccharides, flavonoides, alkaloids. In: Büssing A, editor. 16, Mistletoe the genus viscum. Amsterdam: Harwood Academic Publishers; 2000. p. 101-122.
20. Debreczeni JE, Girmann B, Zeeck A, Kratzner R, Sheldrick GM. Structure of viscotoxin A3: disulfide location from weak SAD data. Acta Crystallogr D Biol Crystallogr. 2003; 59: 2125-2132. doi:10.1107/S0907444903018973
21. Jäger S, Eisenbraun J, Baiér R, Schmid B, Kahle B, Zeeck A, Scheer R. Machbarkeitsstudie zur Entwicklung einer LC MS/MS-Methode zur Bestimmung von Viscotoxin A2 in Ratten-Serum. In: Scheer R, Bauer R, Becker H, Fintelmann V, Kemper, Schilcher, editors. Fortschritte in der Misteltherapie. Aktueller Stand der Forschung und klinischer Anwendung. Essen: KVC-Verlag; 2005. p. 181-189.
22. Winkler K, Jäger S, Leneweit G, Schubert R. Interactions of viscotoxins with vesicles of genuine plant membranes. Planta Med. 2008; 74: 163-167. doi:10.1055/s-2008-1034282
23. Park JH, Hyun CK, Shin HK. Cytotoxic effects of the components in heat-treated mistletoe (Viscum album). Cancer Lett. 1999; 139: 207-213. doi:10.1016/S0304-3835(99)00043-9
24. Pryme IF, M. DT, Tilrem P. Oral mistletoe lectins: A case for their use in cancer therapy. Cancer Ther. 2007; 5: 287-300.
25. Xi J, Chang Q, Chan CK, Meng ZY, Wang GN, Sun JB, Wang YT, Tong HHY, Zheng Y. Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS PharmSciTech. 2009; 10: 172-182. doi:10.1208/s12249-009-9190-9
26. Jeong DW, Kim YH, Kim HH, Ji HY, Yoo SD, Choi WR, Lee SM, Han C-K, Lee HS. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats. Biopharm Drug Dispos. 2007; 28: 51-57. doi:10.1002/bdd.530
27. Akowuah GA, Zhari I. Determination of betulinic acid from Orthosiphon stamineus leaf extract in rat plasma. Pharmazie. 2008; 63: 788-790. doi:10.1691/ph.2008.8596
28. Schroeder F. Fluorescent stoeroles: Probe molecules of membrane structure and function. Prog Lipid Res. 1984; 23: 97-113. doi:10.1016/0163-7827(84)90009-2
29. Pfüller U. Mizellen-Vesikel-Mikroemulsionen Tensidassoziate und ihre Anwendung in Analytik und Biochemie. Berlin: Springer Verlag; 1986.
30. Jäger S. Macherey-Nagel application 303040: Enrichment of viscotoxins from Viscum album L.: Macherey-Nagel, Düren, Germany. Report No.: application No. 303040.
31. Manojlovic V, Winkler K, Bunjes V, Neub A, Schubert R, Bugarski B, Leneweit G. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein. Colloids Surf B Biointerfaces. 2008; 64: 284-296. doi:10.1016/j.colsurfb.2008.02.001